Suppr超能文献

相似文献

5
A phase I dose-finding study of 5-azacytidine in combination with sodium phenylbutyrate in patients with refractory solid tumors.
Clin Cancer Res. 2009 Oct 1;15(19):6241-9. doi: 10.1158/1078-0432.CCR-09-0567. Epub 2009 Sep 29.
8
Phase I Study of CC-486 Alone and in Combination with Carboplatin or nab-Paclitaxel in Patients with Relapsed or Refractory Solid Tumors.
Clin Cancer Res. 2018 Sep 1;24(17):4072-4080. doi: 10.1158/1078-0432.CCR-17-3716. Epub 2018 May 15.
9
Phase 1 study of romidepsin plus erlotinib in advanced non-small cell lung cancer.
Lung Cancer. 2015 Dec;90(3):534-41. doi: 10.1016/j.lungcan.2015.10.008. Epub 2015 Oct 9.

引用本文的文献

1
Prodrugs in Oncology: Bioactivation and Impact on Therapeutic Efficacy and Toxicity.
Int J Mol Sci. 2025 Jan 24;26(3):988. doi: 10.3390/ijms26030988.
2
p53-mediated regulation of LINE1 retrotransposon-derived R-loops.
J Biol Chem. 2025 Mar;301(3):108200. doi: 10.1016/j.jbc.2025.108200. Epub 2025 Jan 17.
3
Orphan nuclear receptor NR2E3 is a new molecular vulnerability in solid tumors by activating p53.
Cell Death Dis. 2025 Jan 14;16(1):15. doi: 10.1038/s41419-025-07337-1.
4
What nature has to offer: Opportunities for immuno-oncology.
J Food Drug Anal. 2023 Jun 15;31(2):212-231. doi: 10.38212/2224-6614.3459.
6
Clinical Utility of Epigenetic Changes in Pancreatic Adenocarcinoma.
Epigenomes. 2021 Sep 27;5(4):20. doi: 10.3390/epigenomes5040020.
7
Advances in epigenetic therapeutics with focus on solid tumors.
Clin Epigenetics. 2021 Apr 20;13(1):83. doi: 10.1186/s13148-021-01069-7.
8
Role of Epigenetic Regulation in Plasticity of Tumor Immune Microenvironment.
Front Immunol. 2021 Apr 2;12:640369. doi: 10.3389/fimmu.2021.640369. eCollection 2021.
10
New Understanding of the Relevant Role of LINE-1 Retrotransposition in Human Disease and Immune Modulation.
Front Cell Dev Biol. 2020 Aug 7;8:657. doi: 10.3389/fcell.2020.00657. eCollection 2020.

本文引用的文献

1
Phase I Study of CC-486 Alone and in Combination with Carboplatin or nab-Paclitaxel in Patients with Relapsed or Refractory Solid Tumors.
Clin Cancer Res. 2018 Sep 1;24(17):4072-4080. doi: 10.1158/1078-0432.CCR-17-3716. Epub 2018 May 15.
2
Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitors.
Cell Cycle. 2018;17(7):811-822. doi: 10.1080/15384101.2018.1442623. Epub 2018 Apr 30.
3
Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden.
Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):E10981-E10990. doi: 10.1073/pnas.1712514114. Epub 2017 Dec 4.
8
A robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of 5-azacytidine.
Biomed Chromatogr. 2016 Mar;30(3):494-6. doi: 10.1002/bmc.3562. Epub 2015 Aug 17.
9
Evaluation of CYP3A-mediated drug-drug interactions with romidepsin in patients with advanced cancer.
J Clin Pharmacol. 2015 Dec;55(12):1378-85. doi: 10.1002/jcph.560. Epub 2015 Jul 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验